Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Elinzanetant for treating vasomotor symptoms associated with menopause [ID6359]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC